financetom
Business
financetom
/
Business
/
US nuclear regulator has not gotten application for Three Mile Island restart
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US nuclear regulator has not gotten application for Three Mile Island restart
Sep 20, 2024 11:24 AM

WASHINGTON (Reuters) - The U.S. Nuclear Regulatory Commission (NRC) said on Friday it has not yet gotten an application from Constellation Energy ( CEG ) on restarting the Three Mile Island nuclear reactor.

Constellation and Microsoft ( MSFT ) have signed a data center deal to help resurrect a reactor by 2028 at Three Mile Island in Pennsylvania. It has been shut since 2019.

"At this point there's nothing in front of us in terms of an application. It's up to Constellation to lay out its rationale for justifying restart, so we're prepared to engage with the company on next steps," said NRC spokesperson Scott Burnell.

Constellation said it had plans to file a permit application but did not immediately specify a timeline for doing so. "We anticipate the NRC review to be complete in 2027," a company spokesperson said.

Nuclear proponents complain that NRC takes too long to review licenses, and a law signed by President Joe Biden this year is meant to help address that. But as demand for power soars for the first time in decades, the NRC is mulling a host of applications from new high-tech nuclear reactors and an application from a decommissioned reactor, in Michigan called Palisades, which if approved could be the first U.S. reactor to come back from restart.

Burnell said the NRC will use existing review processes to consider any licenses for TMI. Some opponents of quickly reopening shuttered nuclear plants have filed a petition at NRC saying the agency should adopt a new rule-making for such cases, as no closed U.S. nuclear power plant has ever been resurrected.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - ESP LN
Form 8.3 - ESP LN
Sep 29, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Kratos Defense Completes Preliminary Design Review for Space Development Agency Program
Kratos Defense Completes Preliminary Design Review for Space Development Agency Program
Sep 29, 2025
10:00 AM EDT, 09/29/2025 (MT Newswires) -- Kratos Defense & Security Solutions (KTOS) said Monday it has completed the preliminary design review for the Space Development Agency's Advanced Fire Control Ground Integration system. The company completed the PDR with zero liens, which allows the program to advance on an accelerated schedule. The technology, products, system and software company said it...
Form 8.3 - UTG LN
Form 8.3 - UTG LN
Sep 29, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Emma Walmsley To Step Down As GSK CEO After Nine Years, Luke Miels To Lead Starting January 2026
Emma Walmsley To Step Down As GSK CEO After Nine Years, Luke Miels To Lead Starting January 2026
Sep 29, 2025
GSK plc ( GSK ) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the Board on January 1, 2026. Luke will succeed the current CEO, Dame Emma Walmsley. He joined GSK in 2017 and is currently Chief Commercial Officer, with worldwide responsibility for medicines and vaccines. He has been instrumental...
Copyright 2023-2026 - www.financetom.com All Rights Reserved